BioSpace News Archive

Business

Takeda and Evotec Enter into Gene Therapy Research Alliance

Takeda Pharmaceutical and a subsidiary of Germany-based Evotec SE forged a long-term research collaboration that will support the Japanese company’s growing number of research stage gene therapy discovery programs.

April 6, 2020
·
2 min read
·
Alex Keown
Drug Development

Biopharma Update on the Novel Coronavirus: April 6

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.

April 6, 2020
·
6 min read
·
BioSpace Editorial Staff
Drug Development

Incyte’s Ruxolitinib Shows Significant Improvement in Atopic Dermatitis Trials

The research was presented at the Revolutionizing Atopic Dermatitis Virtual Symposium.

April 6, 2020
·
3 min read
·
Mark Terry
Drug Development

Immunomedics’ Triple-Negative Breast Cancer Trial Halted Early Due to Compelling Efficacy

“Today’s announcement marks a significant milestone towards fulfilling our promise to patients globally with TNBC of providing a new treatment option that can meaningfully improve their lives,” said Behzad Aghazadeh, executive chairman of Immunomedics.

April 6, 2020
·
2 min read
·
Mark Terry
Policy

Martin Shkreli Pleads for 3-Month Prison Furlough to Help COVID-19 R&D Efforts

Disgraced pharma executive Martin Shkreli is pleading to be temporarily let out of prison in order to join in the fight against COVID-19, the disease that has swept across the globe infecting more than 1.3 million people across the globe.

April 6, 2020
·
3 min read
·
Alex Keown
BioMidwest

Empirical Bioscience’s 2019 RT-qPCR Kit Available For Use in nCoV Assay Testing

Empirical Bioscience announced that their QuanTASE and QuanTASE PLUS One Step RT-qPCR RT-qPCR Kits have been successfully tested in assays using EUA authorized qPCR detection kits using the established CDC testing protocol.

April 6, 2020
·
1 min read
Business

GSK Strikes Deals with Vir Biotechnology and China’s Innovax Biotech Against COVID-19

Following close on the heels of its vaccine development agreement with China’s Xiamen Innovax Biotech, GlaxoSmithKline forged a research and development deal with Vir Biotechnology to develop treatments for COVID-19.

April 6, 2020
·
3 min read
·
Alex Keown
Accruent Launches Free Ventilator Predictive Maintenance Data to Help Hospitals Manage COVID-19 Impact Industry Leader Turns 25 Years of Equipment Maintenance Data Into App for Healthcare Providers

Software provider Accruent announced today that it is offering newly-developed resources to hospitals and medical facilities to assist the healthcare industry in combatting the COVID-19 pandemic

April 6, 2020
·
4 min read
Deals

iTeos Therapeutics Closes $125 Million Series B2 Financing

Proceeds support advancing clinical development of next-generation cancer immunotherapies targeting A2A adenosine receptor and anti-TIGIT immune checkpoint

April 6, 2020
·
4 min read
Drug Development

Menlo’s Serlopitant for Prurigo Nodularis Itching Flunks Two Phase III Trials

Menlo Therapeutics released topline results from two Phase III trials of once daily oral serlopitant for pruritus (itching) associated with prurigo nodularis. Neither trial met their primary endpoint.

April 6, 2020
·
3 min read
·
Mark Terry